Lukas C Heukamp

Author PubWeight™ 0.79^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancer.	Oncotarget	2015	0.79